PropertyValue
?:abstract
  • Due to the COVID-19 pandemic, the Food and Drug Administration issued an Emergency Use Authorization to permit developers of certain serological tests to market their product prior to a comprehensive review. Nonetheless, the reliability of these assays is of great importance in order to be useful as a tool in estimating the relative proportions of different populations that have been exposed to SARS-CoV-2. We provide a sampling of 145 individuals from an ambulatory setting simultaneously tested with a qualitative point of care rapid finger prick Lateral Wave® IgM and IgG assay and a sample for the Mayo Clinic enzyme linked immunosorbent assay (ELISA) IgM/IgG antibody assay. Significant discrepancies did exist between the purported antibody responses as demonstrated by each assay.
is ?:annotates of
?:creator
?:externalLink
?:journal
  • Annals_of_clinical_and_laboratory_science
?:license
  • unk
?:pmid
?:pmid
  • 33334805.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Communication: Correlation of Point of Care SARS-CoV-2 Serological Assay with Quantitative ELISA.
?:type
?:year
  • 2020-11-01

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/bbpyyrbn>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/bbpyyrbn>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all